NEWRON PHARMACEUTICALS SPA (NP5.DE) Stock Cash Flow
FRA:NP5 • IT0004147952
Current stock price
16.65 EUR
-0.6 (-3.48%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -12.35M | 21.39M | -16.20M | -17.47M | -14.88M | |||
| Depreciation Amortization | 172.00K | 192.00K | 201.00K | 202.00K | 209.00K | |||
| Change In Working Capital | 36.87M | -39.60M | 351.00K | 702.00K | -1.06M | |||
| Interest Paid | 3.29M | 1.90M | 1.20M | 1.23M | 869.00K | |||
| Other non cash items | 7.66M | 400.00K | 5.51M | 5.48M | 4.29M | |||
| OPERATING CASH FLOW | 32.35M | -17.61M | -10.14M | -11.09M | -11.45M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -48.00K | -13.00K | -11.00K | -18.00K | -20.00K | |||
| Other Investing Activity | -13.62M | 3.17M | 3.26M | -299.00K | 8.44M | |||
| INVESTING CASH FLOW | -13.66M | 3.16M | 3.25M | -317.00K | 8.42M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -13.78M | -193.00K | -192.00K | -186.00K | 14.83M | |||
| Stock Issued/Repurchased | 350.00K | 15.41M | N/A | N/A | N/A | |||
| Other Financing Activity | 0.00 | -170.00K | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | -13.43M | 15.05M | -192.00K | -186.00K | 14.83M | |||
| CHANGE IN CASH | 5.25M | 595.00K | -7.09M | -11.60M | 11.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 32.35M | -17.61M | -10.14M | -11.09M | -11.45M | |||
| Capital Expenditure | -48.00K | -13.00K | -11.00K | -18.00K | -20.00K | |||
| FREE CASH FLOW | 32.30M | -17.63M | -10.15M | -11.11M | -11.46M | |||
All data in EUR